Related Experiment Video
Updated: Aug 7, 2026

07:17
Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024
Case Report: Early T-cell precursor acute lymphoblastic leukemia with aberrant CD19 expression and an NPM1 mutation
Yan Lu1, Yiran Chen2, Qiaohong Zhang1
1Clinical Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
Frontiers in Oncology
|August 6, 2026
Summary
This case report details the first instance of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) with a nucleophosmin 1 (NPM1) mutation. This rare finding, alongside aberrant CD19 expression, presents diagnostic challenges in leukemia.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a high-risk subtype of T-cell acute lymphoblastic leukemia (T-ALL).
- Aberrant CD19 expression in ETP-ALL can lead to misdiagnosis as mixed-phenotype acute leukemia.
- Nucleophosmin 1 (NPM1) mutations are common in acute myeloid leukemia (AML) but rare in T-ALL.
